The Prevalence of Thalassemia Among Residents of Baghdad: An Epidemiological Survey

Thalassemia Beta major Alpha Exjade

Authors

November 16, 2026

Downloads

Context: Thalassemia is a lifelong blood disease that needs to be treated with regular blood transfusion and iron chelation drugs. Aims: To explore the epidemiology of thalassemia in Baghdad and interventions that are administered. Setting and Design: It is a cross-sectional study that was done at the center of treating thalassemia in Rusafa side of Baghdad in Iran. The sample size was 206, which was involved in the research course in October, 2024 to January, 2025. Methods and Material: Demographics were also obtained of all respondents as well as information about their form of thalassemia, treatments received, adherence to, and type and longevity of treatment. The respondents were 55.8% women, and 44.2% men; the average age of the respondents was 16.88 years (SD ± 8.69). Statistical test employed: Data were analysed with the help of IBM SPSS v28. The continuous variables are given as the mean with SD; categorical variables as the number with percentages. Chi-square tests employed group comparisons (p < 0.05 was taken to be statistically significant). Results: There were more proportions of severely elevated iron in males (47.3% vs. 25.2% of females), and females depended on family funding more to acquire treatment (30.4% vs. 5.5% of males). Hospitals were the center of care delivery, and no participants were treated in other places but the hospitals. Pharmaceutical stores were cited as having medications that are always in stock with 99.0% of the participants, but delays were reported occasionally by 3.4% of the respondents. Conclusions: To maximize results on people with thalassemia, gender-specific issues should be considered, practices of monitoring should be enhanced, and access to care should be a consistent phenomenon. PGT-IVF should be considered as an intervention mechanism to particular cases.